COVID

COVID is an international, peer-reviewed, open access journal on the study of coronaviruses, coronavirus-related diseases and global impact, published monthly online by MDPI.
  • Open Access— free for readers, with article processing charges (APC) paid by authors or their institutions.
  • High Visibility: indexed within ESCI (Web of Science)ScopusCAPlus / SciFinder, and other databases.
  • Journal Rank: CiteScore - Q2 (Immunology and Microbiology (miscellaneous))
  • Rapid Publication: manuscripts are peer-reviewed and a first decision is provided to authors approximately 20.6 days after submission; acceptance to publication is undertaken in 3.4 days (median values for papers published in this journal in the first half of 2025).
  • Recognition of Reviewers: APC discount vouchers, optional signed peer review, and reviewer names published annually in the journal.
Impact Factor: 1.0 (2024); 5-Year Impact Factor: 1.0 (2024)
Add your e-mail address to receive forthcoming issues of this journal:
Special Issue in COVID
Exploring Neuropathology in the Post-COVID-19 Era Guest Editor: Rodrigo Portes Ureshino
Deadline: 30 November 2025
Special Issue in COVID
Post-COVID-19 Muscle Health and Exercise Rehabilitation Guest Editor: Eleni Kortianou
Deadline: 30 November 2025
Special Issue in COVID
COVID and Public Health Guest Editor: Anna Puigdellívol-Sánchez
Deadline: 31 December 2025
Special Issue in COVID
Analysis of Modeling and Statistics for COVID-19, 2nd edition Guest Editors: Martin Kröger, Reinhard Schlickeiser
Deadline: 31 January 2026
Back to TopTop